Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Jefferson Research
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AstraZeneca PLC gives FY 2017 revenue guidance above analysts' estimates


Tuesday, 14 Jan 2014 02:15am EST 

AstraZeneca PLC:Sees FY 2017 revenues to be broadly in line with FY 2013 revenues.The company reported revenue of $25.75 bln in FY 2013.FY 2017 revenues of $22.52 bln - Thomson Reuters I/B/E/S Estimates. 

Company Quote

74.51
-0.21 -0.28%
4:01pm EDT